Behind every clinical trial is a team working to protect participant safety. In our Leadership Spotlight series, we meet the people whose expertise and experience support the delivery of clinical research at Richmond.

In this edition, we spotlight Amina Ghareeb, Head of Pharmacovigilance (PV), about her career journey, the expansion of Richmond's drug safety services and why effective safety oversight is essential throughout clinical development.

‍Background and Career Journey

Amina joined Richmond in August 2022, bringing with her a unique blend of academic knowledge and industry experience. After completing degrees in Anthropology (BSc) and Bioarchaeology (MSc), she went on to build her career in drug safety and pharmacovigilance, gaining experience across both clinical development and post-marketing settings.

Drawn to Richmond by the opportunity to work more closely with clinical trials and contribute to a growing department, Amina joined as a Senior PV Associate. Since then, she has played a key role in the department's development, progressing through the roles of PV Specialist and PV Manager to her current position as Head of PV.

Reflecting on her progression alongside the department, Amina describes the experience as “challenging at times, but incredibly rewarding.”

Throughout her journey, Amina has valued the trust, support and opportunities to develop professionally. Her work also holds personal significance. Born in Iraq, she moved to the UK with her family at the age of 13, an experience that has shaped her perspective on access to medicines and the importance of clinical research.  For Amina, contributing to the safe development of new medicines carries particular significance, reflecting her perspective on access to treatment and the wider impact of clinical research.

Role and Responsibilities

As Head of Pharmacovigilance, Amina leads the team responsible for monitoring and managing medicine safety throughout clinical trials. Working closely with research physicians and investigators, the department ensures that safety concerns are accurately documented, followed up and reported in line with regulatory requirements.

Alongside overseeing safety reporting for trials conducted at Richmond, Amina and her team provide specialist pharmacovigilance services to external sponsors, including safety case processing, regulatory submissions, safety reporting and consultancy. Amina oversees the delivery and continued development of these services, ensuring regulatory compliance, operational quality and participant safety remain central to the team's work.

Behind the Scenes of Pharmacovigilance

No two days are quite the same in pharmacovigilance, with priorities often shifting quickly when safety concerns arise. For Amina, this means balancing immediate safety priorities with longer-term projects, while ensuring her team feels supported, the department continues to develop and participant safety remains at the heart of everything they do.

One challenge that often goes unnoticed is the amount of work involved in producing a single safety report. Information can come from multiple sources, may initially be incomplete and can change as new details emerge. With serious adverse events requiring reporting to the sponsor within 24 hours of the site becoming aware, Amina's team must work quickly without compromising accuracy or quality.

The team brings together information from multiple sources, identifies gaps, coordinates follow-up and ensures reports meet the relevant regulatory and study-specific requirements. They also monitor safety updates from other trial sites to keep investigators informed of emerging concerns.

As Amina highlights, “When done well, the outcome may simply look like a report submitted on time, but it takes considerable coordination, careful assessment, and attention to detail.”

Leading and Developing the Team

For Amina, the success of the PV team comes down to their shared commitment to participant safety, high-quality work and supporting one another. She credits the team's reliability, flexibility and willingness to take ownership, ask questions and raise concerns as key strengths in a safety-focused environment.

When recruiting, Amina looks beyond scientific qualifications, valuing qualities such as curiosity, integrity, sound judgement and clear communication. With the complex and time-sensitive nature of pharmacovigilance, she also emphasises the importance of attention to detail, recognising when further clarification is needed and remaining calm under pressure.

Her approach to developing the team focuses on understanding individual strengths and career aspirations, providing meaningful opportunities to build confidence, independence and progress professionally, while ensuring support is always available.

In Amina's words, “It is that combination of individual responsibility and collaboration that makes the team successful.”

A Proud Career Moment

One of Amina's proudest recent achievements has been co-leading the expansion of Richmond's pharmacovigilance services. Working closely with colleagues across the organisation, she helped develop the business plan, processes, systems and quality framework needed to support the new offering.

The successful launch marked an important milestone for the department, extending Richmond's ability to support sponsors with pharmacovigilance expertise beyond the clinical trials conducted at its own facilities and meeting a shared goal across multiple teams within Richmond.

Looking Ahead: The Future of Pharmacovigilance

What excites Amina the most is that the PV department is still evolving. Having established a strong foundation for overseeing participant safety, the team has expanded its services to support sponsors more broadly throughout clinical development.

As clinical trials become increasingly innovative and complex, Amina sees opportunities to further develop the team’s expertise and explore how data, AI and digital tools can enhance safety oversight and improve efficiency. Above all, she looks forward to the department’s continued contribution to the safe development of medicines that could ultimately improve patients’ lives.

‍Advice for Aspiring PV Professionals  

Amina encourages those considering a career in pharmacovigilance to remain open to different pathways into the field. Drawing on her own unconventional academic background in Anthropology and Bioarchaeology, she highlights the value of transferable skills, curiosity, attention to detail and a willingness to learn.

She also emphasises the importance of understanding the purpose behind PV processes, rather than simply following them, to develop a deeper understanding of the field.

Her advice? “Keep learning, advocate for yourself and be open to opportunities that stretch you.”

‍Beyond Pharmacovigilance: Getting to know Amina

Outside of work, Amina enjoys spending time in nature, hiking and running, having completed the Stockholm Marathon in 2025! She also has a passion for reading, art, philosophy and folklore from different cultures.

Beyond her professional achievements, Amina's approach to leadership reflects the importance she places on people, collaboration and creating opportunities for others to grow.

As she puts it, “Your team is your community at work. For me, leadership is about creating a supportive environment where people feel valued and have the opportunity to flourish.”

‍